Mangalam Drugs And Organics Ltd - Stock Valuation and Financial Performance

BSE: 532637 | NSE: MANGALAM | Pharmaceuticals & Drugs | Small Cap

Mangalam Drugs&Org. Share Price

103.60 -0.35 -0.34%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Mangalam Drugs&Org.

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Mangalam Drugs And Organics stock performance -

P/E Ratio (SA):
15.89
Market Cap:
164 Cr.
52-wk low:
85.2
52-wk high:
144.7

Is Mangalam Drugs And Organics Ltd an attractive stock to invest in?

1. Is Mangalam Drugs And Organics Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Mangalam Drugs And Organics Ltd is a average quality company.

2. Is Mangalam Drugs And Organics Ltd undervalued or overvalued?

The key valuation ratios of Mangalam Drugs And Organics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Mangalam Drugs And Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Mangalam Drugs And Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Mangalam Drugs&Org.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mangalam Drugs And Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 15.7%29.1%30.2%25.4%1.8%10.7%28%18.3%6.7%1.2%-
Value Creation
Index
0.11.11.20.8-0.9-0.21.00.3-0.5-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 221295303279228282385451372369347
Sales YoY Gr.-33.8%2.7%-7.8%-18.5%24.1%36.3%17.3%-17.5%-1%-
Adj EPS 4.711.214.512.3-5.15.217.712.40.8-5.76.5
YoY Gr.-138.9%29.3%-15.4%-141.6%NA240.5%-29.9%-93.5%-811.3%-
BVPS (₹) 22.336.954.265.660.465.782.695.19689.994
Adj Net
Profit
6.216.22319.4-8.18.22819.61.3-910
Cash Flow from Ops. 1421.842.824.621.730.627.625.738.112.2-
Debt/CF from Ops. 5.62.71.52.82.91.62.33.127.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.9%10.1%-1.4%-1%
Adj EPS -202.2%NA-168.5%-811.3%
BVPS16.8%8.3%2.9%-6.3%
Share Price 17.8% 27.9% -3% -17.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
23.635.531.220.5-8.18.223.813.90.8-6.17.1
Op. Profit
Mgn %
9.312.815.516.84.38.415.110.96.94.710.8
Net Profit
Mgn %
2.85.57.67-3.62.97.34.30.3-2.53
Debt to
Equity
2.71.10.80.70.70.50.50.50.50.7-
Working Cap
Days
152130114130162136126131192201107
Cash Conv.
Cycle
675658628347486995709

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.10%

Debt to equity has declined versus last 3 years average to 0.67

Sales growth has been subdued in last 3 years -1.42%

Net Profit has been subdued in last 3 years -168.54%

Sales growth is not so good in last 4 quarters at -2.48%

Latest Financials - Mangalam Drugs And Organics Ltd.

Standalone Consolidated
TTM EPS (₹) 6.5 6.4
TTM Sales (₹ Cr.) 347 347
BVPS (₹.) 94 94.3
Reserves (₹ Cr.) 133 133
P/BV 1.10 1.10
PE 15.89 16.09
From the Market
52 Week Low / High (₹) 85.16 / 144.65
All Time Low / High (₹) 3.43 / 441.50
Market Cap (₹ Cr.) 164
Equity (₹ Cr.) 15.8
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 102 12.976.5 -12.179.8 -288.6 -8.8
Adj EPS (₹) 2.2 N/A1.7 N/A1.7 N/A0.9 178.1
Op. Profit Mgn % 11.48 1121 bps10.70 1469 bps10.90 821 bps9.90 271 bps
Net Profit Mgn % 3.47 829 bps3.51 1441 bps3.36 773 bps1.58 107 bps

Management X-Ray of Mangalam Drugs&Org.:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:50.3%Institutions:0.11%Non-Institutions:49.58%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%10%20%30%40%50%60%
Pledged *16.2216.6520.9320.0417.5218.0817.5814.8810.2611.01
* Pledged shares as % of Promoter's holding (%)

Valuation of Mangalam Drugs&Org.

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Mangalam Drugs&Org.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales221295303279228282385451372369
Operating Expenses 200257257233218259327402347351
Manufacturing Costs21222329272430424550
Material Costs157204196167154195252307250245
Employee Cost 11141923262630373539
Other Costs 11171914121315161617
Operating Profit 20384647102458492617
Operating Profit Margin (%) 9.2%12.7%15.2%16.8%4.3%8.4%15.1%10.9%6.9%4.7%
Other Income 0001010000
Interest 10910129109111314
Depreciation 4457789101115
Exceptional Items 0000000000
Profit Before Tax 6243129-6640282-11
Tax 08992-21281-2
Profit After Tax 6162220-8828201-9
PAT Margin (%) 2.8%5.4%7.4%7.1%-3.5%2.9%7.3%4.4%0.3%-2.5%
Adjusted EPS (₹)4.711.214.112.6-5.15.217.712.40.8-5.7
Dividend Payout Ratio (%)0%0%0%4%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 29538610496104131151152142
Share Capital 13141616161616161616
Reserves 163970888088115135136127
Minority Interest0000000000
Debt71525862594658726888
Long Term Debt39171711947251913
Short Term Debt32354151514251475075
Trade Payables55212138325743559583
Others Liabilities 15342523242432514244
Total Liabilities 170160190227211231264328358357

Fixed Assets

Gross Block9298140156165171197224241261
Accumulated Depreciation394348546270798999113
Net Fixed Assets535493102103101118135142147
CWIP 0500016698
Investments 0020000000
Inventories57473760736559117137124
Trade Receivables44303745184054464728
Cash Equivalents 1010121211
Others Assets14222119152226222149
Total Assets 170160190227211231264328358357

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 14224325223128263812
PBT 6243129-6640282-11
Adjustment 15141718161917222428
Changes in Working Capital -6-121-17116-20-1612-4
Tax Paid 0-4-7-600-9-900
Cash Flow From Investing Activity -4-11-39-16-9-7-31-27-22-18
Capex -4-11-39-16-9-7-31-28-22-18
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -10-11-3-9-11-2333-176
Net Proceeds from Shares 0010000000
Net Proceeds from Borrowing 0-220-6-3-4318-6-5
Interest Paid -10-9-10-12-9-10-9-11-13-14
Dividend Paid 000-1000000
Others 020690-99-4225
Net Cash Flow 100010-11-10
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)23.3638.9132.1120.99-8.058.2723.8313.970.84-6.15
ROCE (%)15.6929.1430.1825.351.7610.6628.0118.346.651.23
Asset Turnover Ratio1.531.841.791.481.181.421.561.521.081.03
PAT to CFO Conversion(x)2.331.381.951.25N/A3.8811.338N/A
Working Capital Days
Receivable Days60453949443445414637
Inventory Days7663495894815971125129
Payable Days8868396483837258109133

Mangalam Drugs And Organics Ltd Stock News

Mangalam Drugs And Organics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Mangalam Drugs&Org. on 21-Feb-2025 16:59 is ₹103.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Mangalam Drugs&Org. stood at ₹164.0.
The latest P/E ratio of Mangalam Drugs&Org. as of 21-Feb-2025 16:59 is 15.89.
The latest P/B ratio of Mangalam Drugs&Org. as of 21-Feb-2025 16:59 is 1.10.
The 52-week high of Mangalam Drugs&Org. is ₹144.7 and the 52-week low is ₹85.16.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mangalam Drugs&Org. is ₹346.7 ( Cr.) .

About Mangalam Drugs And Organics Ltd

Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

The company manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

The Company has a diversified product range having synergies in operations and substantial economies of scale. It is amongst the top three manufacturers in India in almost all the products that it manufactures.

Today Mangalam Drugs & Organics enjoys a very strong brand name in the domestic market. It has over two decades of experience in the industry with a very wide and satisfied customer base.

The company has a state of art multi-product manufacturing facilitiesat Vapi in Gujarat and Sangamner in Maharashtra for production of bulkdrugs perfumery chemicals inorganic chemicals and disperse dyesintermediaries with a strong in-house Research and Development base.

Product range of the company includes:

Active Pharma Ingredients (API)

  • Anti Malarial
  • Analgesic / Anti Inflammatory
  • Diuretic
  • Anti Hypertensive
  • Anti Convulsant

API Under Development

  • Intermediates
  • Antiurolithic

Prefumery / Specialty Chemicals

  • Phenyl Ethyl Alcohol
  • Phenyl Ethyl Methyl Ether
  • Phenyl Ethyl Acetate

Disperse Dye Intermediates

  • Meta Nitro Aniline (Mna)(99-09-2)
  • Meta Amino Propionilide (MAP)
  • Meta Amino Acetanilide (MAA) (162-28-3)
  • Para Amino Acetanilide (PAA) 122-80-5)
  • Para Amino Propionilide (PAP) (59690-89-0)
  • N-Cyano Ethyl Aniline (1075-76-9)
  • N,N-BIS (2-Hydroxy Ethyl) Meta Chloro Aniline (Mangalam-1) (92-00-2)
  • N,N-BIS (2-Acetoxy Ethyl) Meta Chloro Aniline (Mangalam -1A) (26692-46-6) etc.

Achievements/ recognition:

  • Awarded the ISO 9001:2000 Management System Certificate from DNV for Design Development, Manufacture and supply of Bulk Drugs, and Dyes Intermediates.
  • Received the WHO GMP Certificate for its Bulk Drug manufacturing Plant
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on